[1]武文玉,李俊霞,韩广卉,等.不同饮食模式对炎症性肠病的影响研究进展[J].陕西医学杂志,2025,54(12):1717-1723.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.023]
　WU Wenyu,LI Junxia,HAN Guanghui,et al.Research Progress on effects of different dietary patterns on inflammatory bowel disease[J].,2025,54(12):1717-1723.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.023]
点击复制

不同饮食模式对炎症性肠病的影响研究进展

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年12期
页码:
1717-1723
栏目:
综 述
出版日期:
2025-12-05

文章信息/Info

Title:
Research Progress on effects of different dietary patterns on inflammatory bowel disease
作者:
武文玉1; 李俊霞2; 韩广卉1; 孙巍琪1; 张雪萍1; 张涛1; 杨洋1; 许爱丽1; 魏玮1
（1.中国中医科学院望京医院，北京 100102；2.北京大学第一医院，北京 100102）
Author(s):
WU Wenyu1; LI Junxia2; HAN Guanghui1; SUN Weiqi1; ZHANG Xueping1; ZHANG Tao1; YANG Yang1; XU Aili1; WEI Wei1
(1.Wangjing Hospital,China Academy of Chinese Medical Sciences,Beijing 100102,China;2.Peking University First Hospital,Beijing 100102,China)
关键词:
炎症性肠病; 饮食模式; 肠道微生物; 免疫系统; 西方饮食; 地中海饮食; 低FODMAP饮食; 全肠内营养
Keywords:
Inflammatory bowel disease; Dietary patterns; Gut microbiota; Immune system; Western diet; Mediterranean diet; Low FODMAP diet; Exclusive enteral nutrition
分类号:
R 574
DOI:
DOI:10.3969/j.issn.1000-7377.2025.12.023
文献标志码:
A
摘要:
炎症性肠病（IBD）是一种复杂的慢性炎症性疾病。饮食不仅是IBD的一个潜在可逆风险因素，而且通过调节肠道通透性、肠道菌群和免疫系统，可对疾病的发生和进展产生显著影响。饮食管理对IBD综合治疗策略具有重要作用，不同的饮食模式，如西方饮食、地中海饮食、中式饮食，以及低可发酵的单糖、双糖、低聚糖和多元醇（低FODMAP）饮食和全肠内营养（EEN），会对IBD患者病情及肠道微生物群产生不同的影响，也存在各自的挑战。现将这些饮食模式对IBD的影响研究进展进行介绍，从饮食管理角度为IBD患者的临床治疗提供科学依据。
Abstract:
Inflammatory bowel disease (IBD) is a complex chronic inflammatory disorder.Diet is not only a potential reversible risk factor for IBD,but also has a significant impact on the occurrence and progression of the disease by regulating intestinal permeability,intestinal flora and the immune system.Dietary management plays an important role in the comprehensive treatment strategy for IBD.Different dietary patterns,such as Western diet,Mediterranean diet,Chinese diet,low-fermentable oligosaccharides,disaccharides,monosaccharides and polyols (Low FODMAP) diet and exclusive enteral nutrition (EEN),have different effects on the condition of IBD patients and their intestinal microbiota,and each has its own challenges.This article introduces the research progress on the effects of these dietary patterns on IBD,and provides scientific basis for the clinical treatment of IBD patients from the perspective of dietary management.

参考文献/References:

[1]NG S C,SHI H Y,HAMIDI N,et al.Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century:A systematic review of population-based studies[J].Lancet,2017,390(10114):2769-2778.
[2]LI Y,LI Y,WANG J,et al.The burden of inflammatory bowel disease in China:A systematic review and meta-analysis[J].J Gastroenterol Hepatol,2020,35(1):61-70.
[3]YANG H,LI Y,WU W,et al.The incidence of inflammatory bowel disease in Northern China:A prospective population-based study[J].PLoS One,2014,9(7):e101296.
[4]ROGLER G,SINGH A,KAVANAUGH A,et al.Extraintestinal manifestations of inflammatory bowel disease:Current concepts,treatment,and implications for disease management[J].Gastroenterology,2021,161(4):1118-1132.
[5]HAUSMANN A,STEENHOLDT C,NIELSEN O H,et al.Immune cell-derived signals governing epithelial phenotypes in homeostasis and inflammation[J].Trends Mol Med,2024,30(3):239-251.
[6]ATREYA R,NEURATH M F.Biomarkers for personalizing IBD therapy:The quest continues[J].Clin Gastroenterol Hepatol,2024,22(7):1353-1364.
[7]GASINK C,FARRAYE F A.The economic burden of inflammatory bowel disease in the United States[J].J Manag Care Pharm,2020,26(1):34-42.
[8]HUANG Y,CHEN L,CHEN X,et al.Economic burden of inflammatory bowel disease in China:A systematic review[J].J Crohns Colitis,2019,13(11):1437-1446.
[9]NOBLE A J,NOWAK J K,ADAMS A T,et al.Defining interactions between the genome,epigenome,and the environment in inflammatory bowel disease:Progress and prospects[J].Gastroenterology,2023,165(1):44-60.e2.
[10]KAPLAN G G,NG S C.Understanding and preventing the global increase of inflammatory bowel disease[J].Gastroenterology,2017,152(2):313-321.e2.
[11]GUO A,LUDVIGSSON J,BRANTSAETER A L,et al.Early-life diet and risk of inflammatory bowel disease:A pooled study in two Scandinavian birth cohorts[J].Gut,2024,73(4):590-600.
[12]LEE D,BALDASSANO R N,OTLEY A R,et al.Comparative effectiveness of nutritional and biological therapy in North American children with active Crohn’s disease[J].Inflamm Bowel Dis,2015,21:1786-1793.
[13]PETERSSON J,SCHREIBER O,HANSSON G C,et al.Importance and regulation of the colonic mucus barrier in a mouse model of colitis[J].Am J Physiol Gastrointest Liver Physiol,2011,300(2):G327-G333.
[14]DUBINSKY V,RESHEF L,RABINOWITZ K,et al.Escherichia coli strains from patients with inflammatory bowel diseases have disease-specific genomic adaptations[J].J Crohns Colitis,2022,16(10):1584-1597.
[15]GODALA M,GASZYNSKA E,ZATORSKI H,et al.Dietary interventions in inflammatory bowel disease[J].Nutrients,2022,14(20):4261.
[16]MAKKI K,DEEHAN E C,WALTER J,et al.The impact of dietary fiber on gut microbiota in host health and disease[J].Cell Host Microbe,2018,23(6):705-715.
[17]KOPF J C,SUHR M J,CLARKE J,et al.Role of whole grains versus fruits and vegetables in reducing subclinical inflammation and promoting gastrointestinal health in individuals affected by overweight and obesity:A randomized controlled trial[J].Nutr J,2018,17(1):1-13.
[18]ZHENG D,LIWINSKI T,ELINAV E.Interaction between microbiota and immunity in health and disease[J].Cell Res,2020,30(6):492-506.
[19]KOLODZIEJCZYK A A,ZHENG D,ELINAV E.Diet-microbiota interactions and personalized nutrition[J].Nat Rev Microbiol,2019,17(12):742-753.
[20]ZHENG D,LIWINSKI T,ELINAV E.Interaction between microbiota and immunity in health and disease[J].Cell Res,2020,30(6):492-506.
[21]CHELAKKOT C,GHIM J,RYU S H.Mechanisms regulating intestinal barrier integrity and its pathological implications[J].Exp Mol Med,2018,50(8):1-9.
[22]ERIGUCHI Y,NAKAMURA K,YOKOI Y,et al.Essential role of IFN-γ in T cell-associated intestinal inflammation[J].JCI Insight,2018,3(18):e121886.
[23]NEUTRA M R,O'MALLEY L J,SPECIAN R D.Regulation of intestinal goblet cell secretion.Ⅱ.a survey of potential secretagogues[J].Am J Physiol,1982,242(4):G380-G387.
[24]KWON S J,KHAN M S,KIM S G.Intestinal inflammation and regeneration-interdigitating processes controlled by dietary lipids in inflammatory bowel disease[J].Int J Mol Sci,2024,25(2):1311.
[25]CHASSAING B,COMPHER C,BONHOMME B,et al.Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome[J].Gastroenterology,2022,162(3):743-756.
[26]DA COSTA G G,DA CONCEIO NEPOMUCENO G,DA SILVA PEREIRA A,et al.Worldwide dietary patterns and their association with socioeconomic data:An ecological exploratory study[J].Global Health,2022,18(1):31.
[27]SUN Q,BIBI S,XUE Y,et al.Dietary purple potato supplement attenuates DSS-induced colitis in mice:Impact on mitochondrial function[J].J Nutr Biochem,2024,126:109585.
[28]ZHAO L,ZHANG F,DING X,et al.Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J].Science.2018,359(6380):1151-1156.
[29]HINTZE K J,BENNINGHOFF A D,CHO C E,et al.Modeling the western diet for preclinical investigations[J].Adv Nutr,2018,9(3):263-271.
[30]SHEN W,GASKINS H R,MCINTOSH M K.Influence of dietary fat on intestinal microbes,inflammation,barrier function and metabolic outcomes[J].J Nutr Biochem,2014,25(3):270-280.
[31]IN KIM H,KIM J K,KIM J Y,et al.Lactobacillus plantarum LC27 and bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis,endotoxemia,liver steatosis,and obesity in mice[J].Nutr Res,2019,67:78-89.
[32]DEOL P,RUEGGER P,LOGAN G D,et al.Diet high in linoleic acid dysregulates the intestinal endocannabinoid system and increases susceptibility to colitis in mice[J].Gut Microbes,2023,15(1):2229945.
[33]CHEN T,WANG C,NIE C,et al.Galactooligosaccharide or 2’-fucosyllactose modulates gut microbiota and inhibits LPS/TLR4/NF-κB signaling pathway to prevent DSS-induced colitis aggravated by a high-fructose diet in mice[J].J Agric Food Chem,2023,71(24):9349-9360.
[34]MARTINEZ-GONZALEZ M A,MARTIN-CALVO N.Mediterranean diet and life expectancy;beyond olive oil,fruits,and vegetables[J].Curr Opin Clin Nutr Metab Care,2016,19(6):401-407.
[35]CRDENO A,MAGNUSSON M K,STRID H,et al.The unsaponifiable fraction of extra virgin olive oil promotes apoptosis and attenuates activation and homing properties of T cells from patients with inflammatory bowel disease[J].Food Chem,2014,161:353-360.
[36]TURPIN W,DONG M,SASSON G,et al.Crohn’s and colitis canada (CCC) genetic,environmental,microbial (GEM) project research consortium mediterranean-like dietary pattern associations with gut microbiome composition and subclinical gastrointestinal inflammation[J].Gastroenterology,2022,163:685-698.
[37]MARLOW G,ELLETT S,FERGUSON I R,et al.Transcriptomics to study the effect of a mediterranean-inspired diet on inflammation in Crohn’s disease patients[J].Hum Genomics,2013,7(1):24.
[38]GARCA-MATEO S,MARTNEZ-DOMNGUEZ S J,GARGALLO-PUYUELO C J,et al.Healthy lifestyle is a protective factor from moderate and severe relapses and steroid use in inflammatory bowel disease:A prospective cohort study[J].Inflamm Bowel Dis,2025,31(1):95-104.
[39]CHICCO F,MAGR S,CINGOLANI A,et al.Multidimensional impact of mediterranean diet on IBD patients[J].Inflamm Bowel Dis,2021,27(1):1-9.
[40]MORVARIDI M,JAFARIRAD S,SEYEDIAN S S,et al.The effects of extra virgin olive oil and canola oil on inflammatory markers and gastrointestinal symptoms in patients with ulcerative colitis[J].Eur J Clin Nutr,2020,74(6):891-899.
[41]LEWIS J D,SANDLER R S,BROTHERTON C,et al.A randomized trial comparing the specific carbohydrate diet to a mediterranean diet in adults with crohn's disease[J].Gastroenterology,2021,161(3):837-852.e9.
[42]HILLS JR R D,PONTEFRACT B A,MISHCON H R,et al.Gut microbiome:Profound implications for diet and disease[J].Nutrients,2019,11(7):1613.
[43]PIMENTEL M,SAAD R J,LONG M D,et al.ACG clinical guideline:Small intestinal bacterial overgrowth[J].Am J Gastroenterol,2020,115:165-178.
[44]SHAH A,TALLEY N J,JONES M,et al.Small intestinal bacterial overgrowth in irritable bowel syndrome:A systematic review and meta-analysis of case-control studies[J].Am J Gastroenterol,2020,115(2):190-201.
[45]WIECEK M,PANUFNIK P,KANIEWSKA M,et al.Low-FODMAP diet for the management of irritable bowel syndrome in remission of IBD[J].Nutrients,2022,14(21):4562.
[46]COX S R,LINDSAY J O,FROMENTIN S,et al.Effects of low fodmap diet on symptoms,fecal microbiome,and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial[J].Gastroenterology,2020,158:176-188.e7.
[47]PIGNEUR B,LEPAGE P,MONDOT S,et al.Mucosal healing and bacterial composition in response to enteral nutrition vs steroid-based induction therapy-a randomised prospective clinical trial in children with crohn’s disease[J].J Crohns Colitis,2019,13(7):846-855.
[48]LOGAN M,CLARK C M,IJAZ U Z,et al.The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction[J].Aliment Pharmacol Ther,2019,50(6):664-674.
[49]ROLANDSDOTTER H,JNSSON-VIDESTER K,L FAGERBERG U,et al.Exclusive enteral nutrition:Clinical effects and changes in mucosal cytokine profile in pediatric new inflammatory bowel disease[J].Nutrients,2019,11(2):414.
[50]SCHWERD T,FRIVOLT K,CLAVEL T,et al.Exclusive enteral nutrition in active pediatric crohn disease:Effects on intestinal microbiota and immune regulation[J].J Allergy Clin Immunol,2016,138(2):592-596.
[51]KAMARUL ZAMAN M,CHIN K F,RAI V,et al.Fiber and prebiotic supplementation in enteral nutrition:A systematic review and meta-analysis[J].World J Gastroenterol,2015,21(17):5372-5381.
[52]YI B,TITZE J,RYKOVA M,et al.Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects:A longitudinal study[J].Transl Res,2015,166(1):103-110.
[53]SCRIVO R,PERRICONE C,ALTOBELLI A,et al.Dietary habits bursting into the complex pathogenesis of autoimmune diseases:The emerging role of salt from experimental and clinical studies[J].Nutrients,2019,11(5):1013.
[54]魏应凤.高盐饮食对小鼠肠道免疫平衡和TNBS结肠炎影响的研究[D].杭州:浙江大学,2011.
[55]PARADA VENEGAS D,DE LA FUENTE M K,LANDSKRON G,et al.Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases[J].Front Immunol,2019,10:277.
[56]MACIA L,TAN J,VIEIRA A T,et al.Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome[J].Nat Commun,2015,6:6734.
[57]COX M A,JACKSON J,STANTON M,et al.Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines[J].World J Gastroenterol,2009,15(44):5549-5557.
[58]LU D,LIU Y,KANG L,et al.Maternal fiber-rich diet promotes early-life intestinal development in offspring through milk-derived extracellular vesicles carrying miR-146a-5p[J].J Nanobiotechnology,2024,22(1):65.
[59]CHAROENNGAM N,SHIRVANI A,KALAJIAN T A,et al.The effect of various doses of oralvitamin D3 supplementation on gut microbiota in healthy adults:A randomized,double-blinded,dose-response study[J].Anticancer Res,2020,40(1):551-556.
[60]陈风慧,王晓华,范春梅.补充外源性维生素D对老年溃疡性结肠炎患者氧化-抗氧化失衡、肠道黏膜屏障和临床预后的影响[J].陕西医学杂志,2018,47(12):1634-1637.

相似文献/References:

[1]陈红宇,刘亚军,沈 洪△.炎症性肠病患者血清IL-6、sICAM-1及Chemerin的检测及临床价值*[J].陕西医学杂志,2020,49(3):289.
　CHEN Hongyu,LIU Yajun,SHEN Hong..Clinical analysis of serum IL-6,sICAM-1 and Chemerin in patients with inflammatory bowel disease[J].,2020,49(12):289.
[2]谈丹琳,陆惠钢,葛海霞,等.不同病情程度炎症性肠病患儿血清PRDX1 mRNA、IIRPCs蛋白水平变化及临床意义[J].陕西医学杂志,2025,54(12):1697.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.019]
　TAN Danlin,LU Huigang,GE Haixia,et al.Changes and clinical significance of serum PRDX1 mRNA and IIRPCs protein levels in children with inflammatory bowel disease of different severity[J].,2025,54(12):1697.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.019]

备注/Memo

备注/Memo:
国家自然科学基金区域创新发展联合基金资助项目（U22A20375）；国家自然科学基金青年科学基金资助项目（82104851）；中医药防治消化道癌前疾病传承与创新团队（ZYYCXTD-C-202210）；中国中医科学院望京医院高水平中医医院建设项目（WJYY-XZKT-2023-17）
更新日期/Last Update: 2025-12-05